Relationship between familial combined hyperlipidemia and insulin resistance.

Dietary Fructus Schisandrae extracts and fenofibrate regulate the serum/hepatic lipid-profile in normal and hypercholesterolemic mice, with attention to hepatotoxicity. Lipids Health Dis (2012) 0.90

Medullary and mixed medullary-papillary carcinoma of the thyroid gland. Pathologica (1997) 0.78

Complementary insulin therapy improves blood glucose and serum lipid parameters in type 2 (non-insulin-dependent) diabetic patients. I. Effects on blood glucose control. Exp Clin Endocrinol Diabetes (1997) 0.77

Brachial endothelial function in subjects with familial combined hyperlipidemia and its relationships to carotid artery intima-media thickness. Int Angiol (2006) 0.76

Correlation of lipid parameters and markers of insulin resistance: does smoking make a difference? Physiol Res (2014) 0.75

Type III hyperlipoproteinaemia: clinicopathological observation of five cases. Acta Univ Palacki Olomuc Fac Med (1985) 0.75

[Influence of nicotinic acid therapy on liver steatosis]. Cesk Gastroenterol Vyz (1970) 0.75

[Problems with interpretation of low levels of thyroidal hormones conditioned by changes in transport proteins]. Vnitr Lek (2006) 0.75

[Paraneoplastic Cushing's syndrome in metastasizing medullary cancer of the thyroid gland]. Vnitr Lek (1987) 0.75

Effect of manganese ions on HDL2 precipitation with dextran sulfate. Acta Univ Palacki Olomuc Fac Med (1990) 0.75

Correlation of uric acid levels and parameters of metabolic syndrome. Physiol Res (2017) 0.75

[Eye changes in hyperlipoproteinemia]. Cesk Oftalmol (1971) 0.75

[Dyslipoproteinemia and chronic kidney failure]. Vnitr Lek (2000) 0.75

[Obliterative disease of the carotid and peripheral arteries in hyperlipoproteinemia]. Vnitr Lek (1990) 0.75

[Digitalis therapy in clinical practice]. Acta Univ Palacki Olomuc Fac Med (1989) 0.75

[Recommendations for the diagnosis and therapy of hyperlipoproteinemia in childhood and adolescence developed by the Committee of the Czech Society for Atherosclerosis]. Cas Lek Cesk (1998) 0.75

[Treatment with nicotinic acid of patients with ischemic heart disease and hypercholesterolemia. II. Influence on the liver]. Vnitr Lek (1971) 0.75

[Endothelial dysfunction in a family with familial combined hyperlipidemia]. Vnitr Lek (2003) 0.75

[Classification of hyperlipoproteinemias according to the NIH system (typing according to Frederickson and collaborators)]. Vnitr Lek (1972) 0.75

[Experience with the hypolipidemic drug Lipanthyl]. Vnitr Lek (1982) 0.75

[Familial combined hyperlipidemia. I. Variation in the lipoprotein picture]. Vnitr Lek (1986) 0.75

Effect of genetic heterogeneity of hypertriglyceridemia upon the risk of coronary heart disease. Acta Univ Palacki Olomuc Fac Med (1987) 0.75

[Beta-lipoprotein cholesterol: calculation without centrifugation and clinical importance]. Vnitr Lek (1975) 0.75

[Incidence of ischemic heart disease in type V primary hyperlipoproteinemia]. Vnitr Lek (1979) 0.75

[Simultaneous occurrence of 2 thyroid gland carcinomas]. Vnitr Lek (1997) 0.75

[Recommendations for the diagnosis and therapy of hyperlipoproteinemias in adults prepared by the Czech Atherosclerosis Society]. Vnitr Lek (1997) 0.75

[Opinion of the Czech Atherosclerosis Society's committee (CSAT) on the ESC/EAS guidelines related to the diagnostics and treatment of dyslipidemias issued in 2011]. Vnitr Lek (2013) 0.75

[Familial combined hyperlipidemia. II. Risk of ischemic heart disease]. Vnitr Lek (1986) 0.75

Platelet aggregation in primary hyperlipoproteinemia. Acta Univ Palacki Olomuc Fac Med (1985) 0.75

[Influence of nicotinic acid on serum lipids in patients with ischemic heart disease]. Vnitr Lek (1970) 0.75

[Hyperlipoproteinemias in internal medicine and therapeutic possibilities]. Cas Lek Cesk (1975) 0.75

Inverse association of lipoprotein (a) with markers of insulin resistance in dyslipidemic subjects. Physiol Res (2017) 0.75

[Attempt to classify hyperlipidemias into types by the Fredrickson method on the basis of serum cholesterol and triglyceride concentrations]. Cas Lek Cesk (1972) 0.75

[Type II primary hyperlipoproteinemia: effect of dietary treatment and cholestyramine on serum lipids and lipoproteins]. Vnitr Lek (1976) 0.75

Familial combined hyperlipidemia. Part I. Lipid values and the lipoprotein pattern. Acta Univ Palacki Olomuc Fac Med (1986) 0.75

[Classification of hyperlipoproteinemias (author's transl)]. Cas Lek Cesk (1975) 0.75

Hypertriglyceridemic waist - a simple clinical tool to detect cardiometabolic risk: comparison with harmonized definition of metabolic syndrome. Physiol Res (2015) 0.75

[Hypothyroidism and serum lipids]. Acta Univ Palacki Olomuc Fac Med (1993) 0.75

Familial combined hyperlipidemia. Part II. Clinical picture. Acta Univ Palacki Olomuc Fac Med (1986) 0.75

[Ciprofibrate in the treatment of combined hyperlipoproteinemia. Results in more than 600 patients from 23 centers in the Czech Republic]. Vnitr Lek (2000) 0.75

The preheparin and postheparin lipids of high density lipoprotein subfractions: relation to the serum insulin and postheparin plasma lipase activities in normal human. Acta Univ Palacki Olomuc Fac Med (1992) 0.75

[Recommendations for diagnosis and therapy of hyperlipoproteinemias in adulthood prepared by the Czech Atherosclerosis Society]. Cas Lek Cesk (1997) 0.75